Exec-Edge – ExecEdge

Glucotrack Shows Long-Term Accuracy of Implantable Glucose Monitor

Glucotrack Shows Long-Term Accuracy of Implantable Glucose Monitor

By Daniella Parra Glucotrack, Inc. (Nasdaq: GCTK) shared a study highlighting the long-term accuracy of its implantable blood glucose monitoring system as it moves closer to FDA clinical development and eventual commercialization, it said. The results also align with earlier...

Blockchain.com Launches Blockchain Wealth Program for High-Net Investors

Blockchain.com Launches Blockchain Wealth Program for High-Net Investors

By Exec Edge Editorial Staff Blockchain.com officially launched Blockchain Wealth, a bespoke full-service program for high-net-worth individuals and high-volume trading clients, giving select investors access to institutional-grade services the firm says reflect the standards of traditional private banking. Participants in...

Applied Optoelectronics Awarded $20.9M Texas Innovation Grant

Applied Optoelectronics Awarded $20.9M Texas Innovation Grant

By Karen Roman Applied Optoelectronics, Inc. (Nasdaq: AAOI) said it was granted a Texas Semiconductor Innovation Fund grant for $20.9 million to bolster its 210,000 sq. ft. manufacturing expansion in Sugar Land, Texas, which will become one of the largest...

Lightwave Logic Partners with Michael Best as IP Advisor

Lightwave Logic Partners with Michael Best as IP Advisor

By Karen Roman Tech platform Lightwave Logic, Inc. (Nasdaq: LWLG) said it partnered with Michael Best & Friedrich LLP to strengthen the company’s intellectual property practice including invention harvesting, patent preparation and prosecution, and international filing. The law firm will...

CareDx to Acquire Naveris to Expand Into Cancer MRD Testing

CareDx to Acquire Naveris to Expand Into Cancer MRD Testing

By Daniella Parra CareDx (Nasdaq: CDNA) said it signed a definitive agreement to acquire Naveris, a commercial-stage precision oncology diagnostics company, for up to $260 million and will close in the third quarter. Naveris makes NavDx, a blood-based test that...

2U Refinances and Raises Growth Capital

2U Refinances and Raises Growth Capital

By Exec Edge Editorial Staff Many education technology companies spent 2024 and 2025 scaling back. New university partnerships slowed as institutions built internal capacity. Against that backdrop, 2U completed a growth recapitalization, with its existing owners putting growth capital into...

Input your search keywords and press Enter.